Clinical Development & Late Stage Research

HRU and Cost Analysis in EU-5
Erwin De Cock, Scientific Consultant - August 11, 2016
Databases are essential tools for pharmacoeconomic research. While North America has large administrative claims databases, hospital databases, and electronic medical record systems, databases in Europe are scarcer, integrated primary...
Revving up Patient Recruitment
Matthew Kratz, Patient & Physician Recruitment & Retention - July 29, 2016
Our Roadmap to Recruitment series will help you navigate the patient recruitment roadblocks often found during the summer months. Click the links at the end of the post to follow the rest of the series. When the August heat has you...
Observational Studies for Biosimilars | UBC
Stella Mokiou, Research Scientist II, and Erwin De Cock, Scientific Consultant - July 27, 2016
Biosimilar agents are similar but non-identical versions of existing biological drugs and may be authorized for use once the patent on the reference product has expired. Based on a recent market forecast of IMS, biosimilars are...
Self-Perception of Aging
Marielle Bassel, Research Scientist, and Kristin A. Hanson, Scientific Consultant - July 14, 2016
Changes in facial structure and appearance occur as the result of aging, gravity and underlying soft tissue repositioning. Approximately 15 million people in the United States seek cosmetic treatments per year, with eyelid surgery and...
Does your recruitment strategy need re-routing?
Janet Peterson, Director, Patient & Physician Services - July 12, 2016
Our Roadmap to Recruitment series will help you navigate the patient recruitment roadblocks often found during the summer months. Click the links at the end of the post to follow the rest of the series. I moved to Boston recently, and...

Pages